Normunity @normunity
Biotechnology company creating a new class of precision immuno-oncology medicines called immune normalizers that free the body’s normal immunity against cancer. normunity.com Boston, MA and West Haven, CT Joined October 2022-
Tweets12
-
Followers23
-
Following4
-
Likes0
Today is #AdministrativeProfessionalsDay, and the Normunity team is sending a special thank you to Suzanne, who keeps us all on track as a stellar contributor to our success and progress in our fight against cancer.
Today we announced a multi-program collaboration that leverages Alloy’s high-velocity antibody discovery offering to accelerate Normunity’s novel precision #ImmunoOncology pipeline. #ImmuneNormalizers businesswire.com/news/home/2022…
Christina Cho, PhD, Rachel Humphrey, CEO, and Melinda Merchant, SVP Clinical Development enjoying the sessions at SITC #SITC2022
Normunity was well represented at SITC Friday night by our very own CEO Rachel Humphrey who was on stage with the Checkpoints Band! #SITC2022 #Checkpoints
With new #startup, immunotherapy pioneer Lieping Chen tries to turn ‘cold’ tumors ‘hot’ biopharmadive.com/news/normunity… $NXTC $AZN $BMY $MRK
Normunity, which combines the words normal and immunity, is launching out of stealth with a $65 million Series A. The 15-month-old West Haven and Boston-based biotech wants to address T cell exclusion, or when T cells can’t get into tumors. endpts.com/pd-l1-pioneer-…
Congratulations to the Normunity team for today’s exciting launch. Looking forward to great things and #ImmuneNormalizers to come. #NormunityAgainstCancer normunity.com
Normunity has launched with 1) a powerful premise to reach novel I-O targets to free normal immunity, 2) a unique R&D model working with the Lieping Chen lab and 3) strong momentum to advance life-changing medicines for patients. #NormunityAgainstCancer normunity.com
We’re thrilled to unveil Normunity to the biotech world. @BostonGlobe @RLCscienceboss explores our revolutionary approach to novel cancer immunotherapies that free the normal immune system to fight cancer. #NormunityAgainstCancer bostonglobe.com/2022/10/25/bus…
Normunity’s pipeline of novel cancer immunotherapies is drawn from the ongoing & interactive academic-biotech research leveraging proprietary discovery platforms from the lab of Dr. Lieping Chen at Yale School of Medicine. #NormunityAgainstCancer normunity.com
Normunity announces $65 million Series A to expand the frontier of precision immuno-oncology with immune normalizer therapies. Our medicines target unprecedented mechanisms that free the body’s normal immunity against cancer. #NormunityAgainstCancer normunity.com/normunity-anno…
Introducing Normunity, opening new frontiers in immuno-oncology. We reveal hidden mechanisms to free the immune system to work normally against cancer. These are novel targets for our new class of #ImmuneNormalizers to cure cancer. #ImmunoOncology normunity.com
Nathan Moerke @NMoerke
462 Followers 4K Following Scientist interested in drug discovery, regenerative medicine, and techbio. Previously at @harvardmed, @Denalitx, and @STEMCELLTech. All opinions my own.
Yale Ventures @Yale_Ventures
2K Followers 927 Following Helping develop innovations that impact the world's greatest challenges.
L. J. @lmj612
1K Followers 6K Following Libertarian, CPA, (shooting for CFA), interested in Markets, Trading, Austrian Economics, BioTech, Lowcarb, wannabe Trader.. Just trying to learn from you all
Matt Greving @biochemcompsci
505 Followers 3K Following AI-Biological Sciences R&D & Climbing Big Mountains
michael smith @LifeSci_Search
95 Followers 830 Following Father. Husband. Early stage biopharma and advanced therapies executive search. Tweets are my own.
ZHAO Zhao @zhao8721
91 Followers 1K Following
darren @darren43261151
20 Followers 385 Following
Fei Gao @FeiGao46212338
106 Followers 795 Following A PhD student who focus on the regulatory mechanism of adaptive NK cell function.
LifeSci Startup @LSciStartupNews
259 Followers 318 Following Daily newsletter that aggregates the developments of US biotech/life science startups. Sign up FREE: https://t.co/yNr5CMRiK7
Anna Arnal Estapé @annaarnal
166 Followers 434 Following Biòloga, Científica. Apassionada del coneixement.
EricBioTech2022 @EricTech2022
1 Followers 10 Following
Steven Dickman 🇺�... @cbtadvisors
5K Followers 2K Following Founder-CEO of CBT Advisors, a life sciences consultancy. Former venture capitalist w TVM Capital, fmr reporter Nature, Economist. Also @cbtadvisors.bsky.social
Osage Univ. Partners @OUP_VC
1K Followers 724 Following We're a VC fund with a singular focus on university startups. @OsageVP is our sister fund.
krishnan @h2crunner
17 Followers 241 Following
Romain Caplette @RomainCaplette
107 Followers 1K Following Scientist 👨🏼🔬│Business partner at Promega 👨🏼💼│#Biotech Enthusiast 🧬│#Innovation Aficionado 🚀│Tech Lover📱│Art Nerd🖼️ Views are my own
Danielle Lovell @DanielleMLovell
2K Followers 3K Following Biopharma, life science partnering and more
justMe @HELPPPMEEHELPU
507 Followers 775 Following
Matt Vesely MD, PhD F... @mdvesely
285 Followers 273 Following Assistant Professor of Dermatology @yalederm. Immunologist, physician-scientist. Proud dad @yalemed @yaleIBIO #autoimmunity #cancerimmunology #cutaneouslupus
Michelle T. Sullo @writermsullo
899 Followers 2K Following Writer, award winning journalist, volunteer, mom, also tweeting @ghostsanovel. Breaking new editor for Patch in Connecticut and Hudson Valley, New York.
NewHavenBiz @NewHavenBiz
934 Followers 1K Following
Novak Xuan Yang @Novak_XYang
127 Followers 386 Following NIH/NCI F99/K00 Fellow, Postdoctoral Associate @Yale Immunobiology; PhD Immunology @Yale; MS Cancer Biology & Translational Oncology @Emory alumnus
The Boston Globe @BostonGlobe
779K Followers 935 Following New England's leading source for breaking news and analysis.
Endpoints News @endpts
30K Followers 79 Following The biopharma world is here. Get the industry’s most comprehensive daily news reports at https://t.co/qpcDlbaOSx
John Carroll @JohnCendpts
71K Followers 107 Following 47 yrs before the mast. Invented FierceBiotech, founded Endpoints News w/ 243,000 subs. Devoting time to the big showdown with Merkel cell carcinoma . We'll see
Ryan Cross the Scienc... @RLCscienceboss
4K Followers 837 Following Senior Science Correspondent for @Endpts covering biotech, drug discovery, gene editing, RNA, and more. Formerly at Boston Globe and C&EN. Signal: RyanCross.25Trends for United States
You might like
